These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 32156555)

  • 1. Disentangling ingestive behavior-related phenotypes in Prader-Willi syndrome: Integrating information from nonclinical studies and clinical trials to better understand the pathophysiology of hyperphagia and obesity.
    Wevrick R
    Physiol Behav; 2020 May; 219():112864. PubMed ID: 32156555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Testing in Translational Animal Models of Prader-Willi Syndrome: Overview and Gap Analysis.
    Carias KV; Wevrick R
    Mol Ther Methods Clin Dev; 2019 Jun; 13():344-358. PubMed ID: 30989085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Trials in Prader-Willi Syndrome: A Review.
    Mahmoud R; Kimonis V; Butler MG
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calorie seeking, but not hedonic response, contributes to hyperphagia in a mouse model for Prader-Willi syndrome.
    Davies JR; Humby T; Dwyer DM; Garfield AS; Furby H; Wilkinson LS; Wells T; Isles AR
    Eur J Neurosci; 2015 Aug; 42(4):2105-13. PubMed ID: 26040449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study.
    Strong TV; Miller JL; McCandless SE; Gevers E; Yanovski JA; Matesevac L; Bohonowych J; Ballal S; Yen K; Hirano P; Cowen NM; Bhatnagar A
    J Neurodev Disord; 2024 Apr; 16(1):22. PubMed ID: 38671361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prader-Willi syndrome: advances in genetics, pathophysiology and treatment.
    Goldstone AP
    Trends Endocrinol Metab; 2004; 15(1):12-20. PubMed ID: 14693421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in genetic mechanisms of hypothalamic dysfunction in Prader-Willi syndrome.
    Wang XY; Sun R; Gao YQ
    Yi Chuan; 2022 Oct; 44(10):899-912. PubMed ID: 36384726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review.
    Tan Q; Orsso CE; Deehan EC; Triador L; Field CJ; Tun HM; Han JC; Müller TD; Haqq AM
    Obes Rev; 2020 May; 21(5):e12992. PubMed ID: 31889409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prader-Willi syndrome: Hormone therapies.
    Tauber M; Diene G
    Handb Clin Neurol; 2021; 181():351-367. PubMed ID: 34238470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment.
    Höybye C; Barkeling B; Espelund U; Petersson M; Thorén M
    Growth Horm IGF Res; 2003 Dec; 13(6):322-7. PubMed ID: 14624765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
    Höybye C
    Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome.
    McCarthy JM; McCann-Crosby BM; Rech ME; Yin J; Chen CA; Ali MA; Nguyen HN; Miller JL; Schaaf CP
    J Med Genet; 2018 May; 55(5):307-315. PubMed ID: 29496979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
    Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypomethylation of the dopamine transporter (DAT) gene promoter is associated with hyperphagia-related behavior in Prader-Willi syndrome: A case-control study.
    Wieting J; Jahn K; Eberlein CK; Bleich S; Frieling H; Deest M
    Behav Brain Res; 2023 Jul; 450():114494. PubMed ID: 37182741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models for Prader-Willi syndrome.
    Zahova S; Isles AR
    Handb Clin Neurol; 2021; 181():391-404. PubMed ID: 34238473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of serum leptin and LEP/LEPR promoter methylation in Prader-Willi syndrome.
    Wieting J; Jahn K; Buchholz V; Lichtinghagen R; Deest-Gaubatz S; Bleich S; Eberlein CK; Deest M; Frieling H
    Psychoneuroendocrinology; 2022 Sep; 143():105857. PubMed ID: 35803048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.
    Goldstone AP; Holland AJ; Butler JV; Whittington JE
    Int J Obes (Lond); 2012 Dec; 36(12):1564-70. PubMed ID: 22270375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome.
    Oztan O; Zyga O; Stafford DEJ; Parker KJ
    Neurosci Biobehav Rev; 2022 Nov; 142():104870. PubMed ID: 36113782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prader-Willi syndrome Profile: validation of a new measure of behavioral and emotional problems in Prader-Willi syndrome.
    Dykens EM; Roof E; Hunt-Hawkins H
    Orphanet J Rare Dis; 2024 Feb; 19(1):83. PubMed ID: 38395848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome.
    Kuppens RJ; Diène G; Bakker NE; Molinas C; Faye S; Nicolino M; Bernoux D; Delhanty PJ; van der Lely AJ; Allas S; Julien M; Delale T; Tauber M; Hokken-Koelega AC
    Endocrine; 2015 Dec; 50(3):633-42. PubMed ID: 25989955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.